Institutional investors purchased a net $559.8 thousand shares of ASMB during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 67.78% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ACUTA CAPITAL PARTNERS LLC Bought 662.4 Thousand shares of Assembly Biosciences Inc